25–30 Aug 2024
Hilton Chicago
America/Chicago timezone

A new RFQ for the carbon therapy injector at HIT Heidelberg

TUPB023
27 Aug 2024, 16:00
2h
Boulevard (Hilton Chicago)

Boulevard

Hilton Chicago

720 South Michigan Ave Chicago, IL 60605 USA
Poster Presentation MC3.1 Industrial and medical accelerators Tuesday Poster Session

Speaker

Ulrich Ratzinger (Goethe Universität Frankfurt)

Description

The tumor therapy facility HIT, Heidelberg, Germany is in operation with light ion beams up to carbon since 2009. The 7 A MeV, 216.8 MHz synchrotron injector linac with a total length of 5 m is designed for the ion C^(4+) from an ECR ion source. The RFQ accelerates the beam from 8 A keV up to 400 A keV and is at present a bottleneck in beam transmission. After a careful analysis of the beam quality along the RFQ it was decided by HIT to order a new RFQ from Bevatech with higher beam acceptance and with tight mechanical tolerances. Other features are optimized entrance and exit gaps by including longitudinal field components, which are characteristic for 4-Rod-RFQs. A complete dipole field compensation along the mini-vane electrodes is another improvement. This RFQ is scheduled to replace the old one in 2026.

Primary author

Ulrich Ratzinger (Goethe Universität Frankfurt)

Co-authors

Andreas Peters (Heidelberg Ionenstrahl-Therapie Centrum) Chuan Zhang (GSI Helmholtzzentrum für Schwerionenforschung GmbH) Dr Hendrik Hähnel (Goethe Universität Frankfurt) Holger Hoeltermann (BEVATECH) Holger Podlech (Goethe Universität Frankfurt) Maximilian Schuett (GSI Helmholtzzentrum für Schwerionenforschung GmbH) Rainer Cee (Heidelberg Ionenstrahl-Therapie Centrum) Seval Altürk (BEVATECH) Thomas Haberer (Heidelberg Ionenstrahl-Therapie Centrum)

Presentation materials

There are no materials yet.